Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis A Altamura

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
The Journal of Infectious Diseases|June 12, 2020
Airborne SARS-CoV-2 Is Rapidly Inactivated by Simulated SunlightMichael Schuit, Shanna Ratnesar-Shumate, Jason Yolitz, et al.
Science Advances|July 17, 2019
GP38-targeting monoclonal antibodies protect adult mice against lethal Crimean-Congo hemorrhagic fever virus infectionJoseph W Golden, Charles J Shoemaker, Michael E Lindquist, et al.
Journal of Virology|May 31, 2013
IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virusRajini Mudhasani, Julie P Tran, Cary Retterer, et al.
Science Translational Medicine|March 30, 2018
A conserved transcriptional response to intranasal Ebola virus exposure in nonhuman primates prior to onset of feverEmily Speranza, Sandra L Bixler, Louis A Altamura, et al.
Scientific Reports|April 26, 2018
Virus-encoded miRNAs in Ebola virus diseaseJanice Duy, Anna N Honko, Louis A Altamura, et al.
Msphere|July 3, 2020
Increasing Temperature and Relative Humidity Accelerates Inactivation of SARS-CoV-2 on SurfacesJennifer Biryukov, Jeremy A Boydston, Rebecca A Dunning, et al.
Microorganisms|April 3, 2021
Transcriptomic Analysis Reveals Host miRNAs Correlated with Immune Gene Dysregulation during Fatal Disease Progression in the Ebola Virus Cynomolgus Macaque Disease ModelChristopher P Stefan, Catherine E Arnold, Charles J Shoemaker, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|November 1, 2022
Comparison of Dose-Response Relationships for Two Isolates of SARS-CoV-2 in a Nonhuman Primate Model of Inhalational COVID-19Paul A Dabisch, Jaleal S Sanjak, Jeremy A Boydston, et al.
Plos Pathogens|August 23, 2021
Seroconversion and fever are dose-dependent in a nonhuman primate model of inhalational COVID-19Paul A Dabisch, Jennifer Biryukov, Katie Beck, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
The Journal of Infectious Diseases|June 12, 2020
Airborne SARS-CoV-2 Is Rapidly Inactivated by Simulated SunlightMichael Schuit, Shanna Ratnesar-Shumate, Jason Yolitz, et al.
Science Advances|July 17, 2019
GP38-targeting monoclonal antibodies protect adult mice against lethal Crimean-Congo hemorrhagic fever virus infectionJoseph W Golden, Charles J Shoemaker, Michael E Lindquist, et al.
Journal of Virology|May 31, 2013
IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virusRajini Mudhasani, Julie P Tran, Cary Retterer, et al.
Science Translational Medicine|March 30, 2018
A conserved transcriptional response to intranasal Ebola virus exposure in nonhuman primates prior to onset of feverEmily Speranza, Sandra L Bixler, Louis A Altamura, et al.
Scientific Reports|April 26, 2018
Virus-encoded miRNAs in Ebola virus diseaseJanice Duy, Anna N Honko, Louis A Altamura, et al.
Msphere|July 3, 2020
Increasing Temperature and Relative Humidity Accelerates Inactivation of SARS-CoV-2 on SurfacesJennifer Biryukov, Jeremy A Boydston, Rebecca A Dunning, et al.
Microorganisms|April 3, 2021
Transcriptomic Analysis Reveals Host miRNAs Correlated with Immune Gene Dysregulation during Fatal Disease Progression in the Ebola Virus Cynomolgus Macaque Disease ModelChristopher P Stefan, Catherine E Arnold, Charles J Shoemaker, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|November 1, 2022
Comparison of Dose-Response Relationships for Two Isolates of SARS-CoV-2 in a Nonhuman Primate Model of Inhalational COVID-19Paul A Dabisch, Jaleal S Sanjak, Jeremy A Boydston, et al.
Plos Pathogens|August 23, 2021
Seroconversion and fever are dose-dependent in a nonhuman primate model of inhalational COVID-19Paul A Dabisch, Jennifer Biryukov, Katie Beck, et al.
Pageof 3